Decreased orexigenic response to neuropeptide Y in rats with obstructive cholestasis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 3 43-3, 2001, Pages

  Rioux, Kevin P ^a   Le, Tai ^a   Swain, Mark G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anorexia; Biliary obstruction; Cytokine; Hypothalamus

Indexed keywords

BRAIN RECEPTOR; NEUROPEPTIDE Y; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; BILE DUCT OBSTRUCTION; CHOLESTASIS; CONTROLLED STUDY; FOOD INTAKE; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0035010853     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.3.g449     Document Type: Article

References (40)

1. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, and Leibowitz SF. Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res 665: 201-212, 1994.
2. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, and Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system that lacks noradrenaline in the rat. Brain Res 331: 172-175, 1985.
3. Ballinger AB, McHugh M, Catnach SM, Alstead EM, and Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 35: 467-470, 1994.
4. Bemelmans MHA, Gouma DJ, Greve JW, and Buurman WA. Cytokines tumour necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 15: 1132-1136, 1992.
5. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, and Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 15: 220-224, 1992.
6. Bonaz B, Plourde V, and Taché Y. Abdominal surgery induces c-fos expression in the hypothalamus and the nucleus tractus solitarius (Abstract). Gastroenterology 104: A815, 1993.
7. Cameron GR and Oakley CL. Ligation of the common bile duct. J Pathol Bacteriol 35: 769-798, 1932.
8. Chance WT, Balasubramaniam A, Thompson H, Mohapatra B, Ramo J, and Fisher JE. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides 17: 797-801, 1996.
9. Chua SC, Leibel RL, and Hirsch J. Food deprivation and age modulate neuropeptide gene expression in the murine hypothalamus and adrenal gland. Mol Brain Res 9: 95-101, 1991.
10. Clark JT, Kalra PS, Crowley WR, and Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behaviour in rats. Endocrinology 115: 427-429, 1984.
11. Clements WDB, Parks R, Erwin P, Halliday MI, Barr J, and Rowlands BJ. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39: 587-593, 1996.
12. Dowling RH and McIntyre N. Biliary tract diseases. Oxford Textbook of Clinical Hepatology. New York: Oxford Univ. Press, 1991, p. 1128-1129.
13. Fantino M and Wieteska L. Evidence for a direct central anorectic effect of TNF-α in the rat. Physiol Behav 53: 477-483, 1993.
14. Galbraith RA, Chua SC, and Kappas A. Hypothalamic mechanism for cobalt protoporphyrin-induced hypophagia and weight-loss: inhibition of the feeding response to neuropeptide Y. Mol Brain Res 15: 298-302, 1992.
15. Gouma DJ, Roughneen PT, Kumar S, Moody FG, and Rowlands BJ. Changes in nutritional status associated with obstructive jaundice and biliary drainage in rats. Am J Clin Nutr 44: 362-369, 1986.
16. Greve NW, Maessen JG, Tiebosch T, Buurman WA, and Gouma DJ. Prevention of postoperative complications in jaundiced rats. Ann Surg 212: 221-227, 1990.
17. Kalra SP, Dube MG, Sahu A, Phelps CP, and Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88: 10931-10935, 1991.
18. Lang ME, Jourd'Heuil D, Meddings JB, and Swain MG. Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis. Gastroenterology 108: 1479-1486, 1995.
19. Levine AS and Morley JE. Neuropeptide Y: a potent inducer of consummatory behaviour in rats. Peptides 5: 1025-1029, 1984.
20. Levinson MJ. A practical approach to nutritional support in liver disease. Gastroenterologist 3: 234-240, 1995.
21. Li B-H, Xu B, Rowland NE, and Kalra SP. c-fos Expression in the rat brain following central administration of neuropeptide Y and effects on food consumption. Brain Res 665: 277-284, 1994.
22. Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
23. Ma Z, Meddings JB, and Lee SS. Membrane physical properties determine cardiac β-adrenergic receptor function in cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 267: G87-G93, 1994.
24. Martel J-C, St-Pierre S, and Quirion R. Neuropeptide Y receptors in rat brain: autoradiographic localization. Peptides 7: 55-60, 1986.
25. McHugh K, Castonguay TW, Collins SM, and Weingarten HP. Characterization of suppression of food intake following acute colon inflammation in the rat. Am J Physiol Regulatory Integrative Comp Physiol 265: R1001-R1005, 1993.
26. McMahon CD, Buxton DF, Elsasser TH, Gunter DR, Sanders CG, Steele BP, and Sartin JL. Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxemic sheep. J Endocrinol 161: 333-339, 1999.
27. O'Neil S, Hunt J, Filkins J, and Gamelli R. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-α and systemic and tissue tumor necrosis factor-α levels after endotoxin. Surgery 122: 281-287, 1997.
28. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic, 1990.
29. Plata-Salaman CR. Anorexia during acute and chronic disease. Nutrition 12: 69-78, 1996.
30. Sabol SL and Higuchi H. Transcriptional regulation of the neuropeptide Y gene by nerve growth factor: antagonism by glucocorticoids and potentiation by adenosine 3′,5′-monophosphate and phorbol ester. Mol Endocrinol 4: 384-392, 1990.
31. Sagar SM, Sharp FR, and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-1331, 1988.
32. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, and Moldawer LL. Anticachectin/ tumor necrosis factor-α antibodies attenuate development of cachexia in tumour models. FASEB J 3: 1956-1962, 1989.
33. Smith GP. The peripheral control of appetite. Lancet 2: 88-89, 1983.
34. Stanley BG and Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35: 2635-2642, 1984.
35. Swain MG and Maric M. Prevention of immune-mediated arthritis in cholestatic rats: involvement of endogenous glucocorticoids. Gastroenterology 107: 1469-1474, 1994.
36. Swain MG and Marie M. Impaired stress and interleukin-1β-induced hypothalamic expression of neuronal activation marker FOS in cholestatic rats. Hepatology 24: 914-918, 1996.
37. Swain MG, Appleyard CB, Wallace JL, and Marie M. Tumour necrosis factor-α facilitates inflammation-induced glucocorticoid secretion in rats with biliary obstruction. J Hepatol 26: 361-368, 1996.
38. Tan Puntis MC and Jiang WG. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J Gastroenterol Hepatol 11: 7-13, 1996.
39. Tempel DL and Leibowitz SF. Glucocorticoid receptors in PVN: interactions with NE, NPY, and Gal in relation to feeding. Am J Physiol Endocrinol Metab 265: E794-E800, 1993.
40. Turner MB, Corp ES, and Galbraith RA. Lack of NPY-induced feeding in cobalt protoporphyrin-treated rats is a post-receptor defect. Physiol Behav 56: 1009-1014, 1994.